These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 34545187)

  • 1. The interactions of Bcl9/Bcl9L with β-catenin and Pygopus promote breast cancer growth, invasion, and metastasis.
    Vafaizadeh V; Buechel D; Rubinstein N; Kalathur RKR; Bazzani L; Saxena M; Valenta T; Hausmann G; Cantù C; Basler K; Christofori G
    Oncogene; 2021 Oct; 40(43):6195-6209. PubMed ID: 34545187
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A cytoplasmic role of Wnt/β-catenin transcriptional cofactors Bcl9, Bcl9l, and Pygopus in tooth enamel formation.
    Cantù C; Pagella P; Shajiei TD; Zimmerli D; Valenta T; Hausmann G; Basler K; Mitsiadis TA
    Sci Signal; 2017 Feb; 10(465):. PubMed ID: 28174279
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Wnt status-dependent oncogenic role of BCL9 and BCL9L in hepatocellular carcinoma.
    Huge N; Sandbothe M; Schröder AK; Stalke A; Eilers M; Schäffer V; Schlegelberger B; Illig T; Vajen B; Skawran B
    Hepatol Int; 2020 May; 14(3):373-384. PubMed ID: 31440992
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Parsing β-catenin's cell adhesion and Wnt signaling functions in malignant mammary tumor progression.
    Buechel D; Sugiyama N; Rubinstein N; Saxena M; Kalathur RKR; Lüönd F; Vafaizadeh V; Valenta T; Hausmann G; Cantù C; Basler K; Christofori G
    Proc Natl Acad Sci U S A; 2021 Aug; 118(34):. PubMed ID: 34408016
    [TBL] [Abstract][Full Text] [Related]  

  • 5. USP9X-mediated deubiquitination of B-cell CLL/lymphoma 9 potentiates Wnt signaling and promotes breast carcinogenesis.
    Shang Z; Zhao J; Zhang Q; Cao C; Tian S; Zhang K; Liu L; Shi L; Yu N; Yang S
    J Biol Chem; 2019 Jun; 294(25):9844-9857. PubMed ID: 31073027
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pax6-dependent, but β-catenin-independent, function of Bcl9 proteins in mouse lens development.
    Cantù C; Zimmerli D; Hausmann G; Valenta T; Moor A; Aguet M; Basler K
    Genes Dev; 2014 Sep; 28(17):1879-84. PubMed ID: 25184676
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mutations in
    Cantù C; Felker A; Zimmerli D; Prummel KD; Cabello EM; Chiavacci E; Méndez-Acevedo KM; Kirchgeorg L; Burger S; Ripoll J; Valenta T; Hausmann G; Vilain N; Aguet M; Burger A; Panáková D; Basler K; Mosimann C
    Genes Dev; 2018 Nov; 32(21-22):1443-1458. PubMed ID: 30366904
    [TBL] [Abstract][Full Text] [Related]  

  • 8. BCL9/BCL9L promotes tumorigenicity through immune-dependent and independent mechanisms in triple negative breast cancer.
    Wang X; Feng M; Xiao T; Guo B; Liu D; Liu C; Pei J; Liu Q; Xiao Y; Rosin-Arbesfeld R; Shi Y; Zhou Y; Yang M; Feng YX; Jiang Y; Shao Z; Yu K; Zhu D
    Oncogene; 2021 Apr; 40(16):2982-2997. PubMed ID: 33767438
    [TBL] [Abstract][Full Text] [Related]  

  • 9. BCL9-2 promotes early stages of intestinal tumor progression.
    Brembeck FH; Wiese M; Zatula N; Grigoryan T; Dai Y; Fritzmann J; Birchmeier W
    Gastroenterology; 2011 Oct; 141(4):1359-70, 1370.e1-3. PubMed ID: 21703997
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bcl9/Bcl9l are critical for Wnt-mediated regulation of stem cell traits in colon epithelium and adenocarcinomas.
    Deka J; Wiedemann N; Anderle P; Murphy-Seiler F; Bultinck J; Eyckerman S; Stehle JC; André S; Vilain N; Zilian O; Robine S; Delorenzi M; Basler K; Aguet M
    Cancer Res; 2010 Aug; 70(16):6619-28. PubMed ID: 20682801
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Tumor-Suppressor WWOX and HDAC3 Inhibit the Transcriptional Activity of the β-Catenin Coactivator BCL9-2 in Breast Cancer Cells.
    El-Hage P; Petitalot A; Monsoro-Burq AH; Maczkowiak F; Driouch K; Formstecher E; Camonis J; Sabbah M; Bièche I; Lidereau R; Lallemand F
    Mol Cancer Res; 2015 May; 13(5):902-12. PubMed ID: 25678599
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The BCL9-2 proto-oncogene governs estrogen receptor alpha expression in breast tumorigenesis.
    Zatula N; Wiese M; Bunzendahl J; Birchmeier W; Perske C; Bleckmann A; Brembeck FH
    Oncotarget; 2014 Aug; 5(16):6770-87. PubMed ID: 25149534
    [TBL] [Abstract][Full Text] [Related]  

  • 13. BCL9 promotes epithelial mesenchymal transition and invasion in cisplatin resistant NSCLC cells via β-catenin pathway.
    Zhang Y; Zhang Q; Chen H; Wang C
    Life Sci; 2018 Sep; 208():284-294. PubMed ID: 30009824
    [TBL] [Abstract][Full Text] [Related]  

  • 14. BCL9-2 binds Arm/beta-catenin in a Tyr142-independent manner and requires Pygopus for its function in Wg/Wnt signaling.
    Hoffmans R; Basler K
    Mech Dev; 2007 Jan; 124(1):59-67. PubMed ID: 17113272
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cell-type-specific function of BCL9 involves a transcriptional activation domain that synergizes with beta-catenin.
    Sustmann C; Flach H; Ebert H; Eastman Q; Grosschedl R
    Mol Cell Biol; 2008 May; 28(10):3526-37. PubMed ID: 18347063
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nerve growth factor modulates the tumor cells migration in ovarian cancer through the WNT/β-catenin pathway.
    Li B; Cai S; Zhao Y; He Q; Yu X; Cheng L; Zhang Y; Hu X; Ke M; Chen S; Zou M
    Oncotarget; 2016 Dec; 7(49):81026-81048. PubMed ID: 27835587
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cross-talk of WNT and FGF signaling pathways at GSK3beta to regulate beta-catenin and SNAIL signaling cascades.
    Katoh M; Katoh M
    Cancer Biol Ther; 2006 Sep; 5(9):1059-64. PubMed ID: 16940750
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeted disruption of the BCL9/β-catenin complex inhibits oncogenic Wnt signaling.
    Takada K; Zhu D; Bird GH; Sukhdeo K; Zhao JJ; Mani M; Lemieux M; Carrasco DE; Ryan J; Horst D; Fulciniti M; Munshi NC; Xu W; Kung AL; Shivdasani RA; Walensky LD; Carrasco DR
    Sci Transl Med; 2012 Aug; 4(148):148ra117. PubMed ID: 22914623
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The function of BCL9 in Wnt/beta-catenin signaling and colorectal cancer cells.
    de la Roche M; Worm J; Bienz M
    BMC Cancer; 2008 Jul; 8():199. PubMed ID: 18627596
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression profiling of in vivo ductal carcinoma in situ progression models identified B cell lymphoma-9 as a molecular driver of breast cancer invasion.
    Elsarraj HS; Hong Y; Valdez KE; Michaels W; Hook M; Smith WP; Chien J; Herschkowitz JI; Troester MA; Beck M; Inciardi M; Gatewood J; May L; Cusick T; McGinness M; Ricci L; Fan F; Tawfik O; Marks JR; Knapp JR; Yeh HW; Thomas P; Carrasco DR; Fields TA; Godwin AK; Behbod F
    Breast Cancer Res; 2015 Sep; 17():128. PubMed ID: 26384318
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.